+RNAinsight® for Hereditary Cancer
Hereditary Cancer Risk Assessment
CommercialActive
Key Facts
About Ambry Genetics
Ambry Genetics is a leading, well-established clinical genetic testing laboratory with a 25-year history. Its core business focuses on diagnostic services for hereditary cancer and rare diseases, leveraging proprietary technologies like +RNAinsight™ and the Patient for Life™ reanalysis program to improve diagnostic yield and accuracy. The company operates a services-based business model, generating revenue from test fees, and has processed over one million tests, demonstrating significant market adoption. Ambry emphasizes scientific rigor, participates in landmark research, and offers digital health tools like the Ambry CARE Program® to identify at-risk patients.
View full company profileTherapeutic Areas
Other Hereditary Cancer Risk Assessment Drugs
| Drug | Company | Phase |
|---|---|---|
| Hereditary Tumor Gene Panel | DeltaGene | Commercial |
| Oncology Test | Genematrix | Commercial |